A dedicated Phase 3 liver disease trial for retatrutide is currently underway
Lamictal XR is available as a 25 mg, 50 mg, 100 mg, 200 mg, 250 mg, and 300 mg extended-release oral tablet
References Khan MAB, Hashim MJ, King JK, Govender RD, Mustafa H, Al Kaabi J
We are taking a new direction at Allurion by focusing on next-generation R&D with a strategic partner that has deep experience developing and manufacturing drug-eluting devices and has a global footprint in bariatrics, advancing our prospective clinical trial on low-dose GLP-1 combination therapy, and transitioning to distributors who have access to physician networks that can offer comprehensive obesity care
When to seek medical advice: If you experience muscle pain, weakness, or dark urine whilst taking statins (potential signs of myopathy) If severe, persistent abdominal pain occurs whilst on GLP-1 therapy (potential pancreatitis) If cholesterol reduction is not achieved despite treatment adherence Before stopping or changing any prescribed medication If you develop new symptoms or side effects from any therapy Patients should discuss their individual cardiovascular risk profile and treatment options with their GP or specialist
Retatrutide diarrhea compared to tirzepatide and semaglutide If you are switching to retatrutide from another GLP-1 agonist, or choosing between them, understanding the comparative GI profiles helps set accurate expectations
